The study revealed that SEPT2 and SEPT7 play an important role in cell migration and invasion in breast cancers by controlling the activation of MEK/ERK MAPKs, and that targeting septin proteins may provide a new direction for breast cancer treatment [45]. This evidence concerns the gene MAP2K7 and breast carcinoma.